SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-20-017885
Filing Date
2020-08-14
Accepted
2020-08-14 06:06:09
Documents
54
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q wint20200630_10q.htm 10-Q 764224
2 EXHIBIT 10.3 ex_199516.htm EX-10.3 41670
3 EXHIBIT 31.1 ex_199468.htm EX-31.1 13297
4 EXHIBIT 31.2 ex_199469.htm EX-31.2 13266
5 EXHIBIT 32.1 ex_199470.htm EX-32.1 8317
  Complete submission text file 0001437749-20-017885.txt   3627144

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT wint-20200630.xml EX-101.INS 544290
7 XBRL TAXONOMY EXTENSION SCHEMA wint-20200630.xsd EX-101.SCH 41771
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE wint-20200630_cal.xml EX-101.CAL 30665
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wint-20200630_def.xml EX-101.DEF 323626
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE wint-20200630_lab.xml EX-101.LAB 263149
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wint-20200630_pre.xml EX-101.PRE 333049
Mailing Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976
Business Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 2154889300
WINDTREE THERAPEUTICS INC /DE/ (Filer) CIK: 0000946486 (see all company filings)

IRS No.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39290 | Film No.: 201101181
SIC: 2836 Biological Products, (No Diagnostic Substances)